Drug Report History #276029

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language (Changed) Updated to: French Was: English
Date Updated 2026-01-15 2026-01-15
Drug Identification Number 02220261 02220261
Brand name PENICILLIN G SODIUM FOR INJECTION, USP PENICILLIN G SODIUM FOR INJECTION, USP
Common or Proper name Penicillin G Sodium for Injection, USP 1 million units vial Penicillin G Sodium for Injection, USP 1 million units vial
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients PENICILLIN G PENICILLIN G
Strength(s) 1000000UNIT 1000000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1 MIU 1 MIU
Additional packaging sizes
ATC code J01CE J01CE
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2026-01-14 2026-01-14
Estimated end date 2026-02-09 2026-02-09
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that we have encountered a supply interruption on our Penicillin G Sodium for Injection, USP 1 million units, vial 15 mL effective immediately, until February 9, 2026. Fresenius Kabi Canada regrets to advise that we have encountered a supply interruption on our Penicillin G Sodium for Injection, USP 1 million units, vial 15 mL effective immediately, until February 9, 2026.
Health Canada comments